Medical Condition News

RSS

Novel artificial intelligence technology improves eye disease diagnosis

Non-invasive eye scans allow doctors a zoomed-in, three-dimensional look beneath the eye's surface without causing discomfort or pain to the patient.

5 Jun 2026

Favorable lifestyle factors reduce dementia risk across key genetic profiles

With dementia cases expected to nearly triple worldwide by 2050, researchers are increasingly focused on identifying ways to prevent or delay the disease.

5 Jun 2026

American Heart Association introduces new certification for stroke coordinators

Stroke remains a leading cause of death and disability in the United States, underscoring the need for effective, coordinated evidence–based care across hospitals and health systems.

5 Jun 2026

Hidden junk DNA could play decisive role in cancer

Many repetitive regions of the genome have been considered "junk DNA" because the technologies available did not allow them to be studied at sufficient resolution.

5 Jun 2026

Major trials show finerenone preserves kidney function beyond diabetes

A series of major studies has shown that finerenone preserves kidney function, reduces cardiovascular risk, and improves survival across a much broader range of patients with chronic kidney disease (CKD) than it is currently recommended for.

5 Jun 2026

Review highlights TIGIT as a promising second-generation immunotherapy target

Malignant tumors remain a major threat to human health, with conventional therapies and first-generation immune checkpoint inhibitors (ICIs) facing limitations like drug resistance and low response rates.

5 Jun 2026

Antibody fragment offers safer alternative for Alzheimer disease treatment

In 2025, the European Medicines Agency approved two antibodies for Alzheimer's disease: lecanemab (Leqembi, from Biogen) and donanemab (KisunlaTM, from Eli Lilly and Company), both based on immunotherapy (the use of molecules from the immune system to treat diseases).

5 Jun 2026

Biopsy-driven treatment strategy improves clinical outcomes in psoriatic arthritis

The management of psoriatic arthritis is increasingly focused on the early identification of clinical, immunological, and tissue-based phenotypes predictive of therapeutic response.

5 Jun 2026

EULAR Congress highlights innovative support strategies for rheumatology patients

Rheumatic and musculoskeletal diseases (RMD) profoundly impact daily life, limiting both work ability and participation in everyday activities.

5 Jun 2026

Study reveals distinct sociodemographic risk factors in rare myopathies

Idiopathic inflammatory myopathies (IIM) are a heterogenous group of autoimmune conditions with substantial morbidity.

5 Jun 2026

New review provides practical guidance for longitudinal cardiovascular research

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Cardiovascular disease develops through gradual accumulation of risk factors and progressive vascular damage.

5 Jun 2026

NWSL and American Heart Association expand CPR awareness efforts

To raise awareness of CPR, the American Heart Association, a relentless force changing the future of health for everyone everywhere, and the National Women's Soccer League (NWSL) today unveiled the 2026 Nation of Lifesavers NWSL Ambassador Class during National CPR and AED Awareness Week, held annually from June 1-7.

4 Jun 2026

Common hypertension drugs tied to worse kidney outcomes in T2D patients

New research presented at the 63rd ERA Congress suggests that a widely used class of blood pressure medications may be associated with poorer kidney outcomes in people with type 2 diabetes (T2D), even among patients already receiving modern kidney-protective treatments.

4 Jun 2026

Finerenone slows kidney function decline in non-diabetic patients

The drug finerenone significantly slows the decline in kidney function in patients with chronic kidney disease (CKD) who do not have diabetes.

4 Jun 2026

Sustained weight loss reduces risk of future atrial fibrillation

Announcing a new article publication for Cardiovascular Innovations and Applications journal. The long-term effects of sustained weight gain and loss on atrial fibrillation (AF) risk remain unclear.

4 Jun 2026

Amplified Sciences secures investment for pancreatic cyst diagnostic assay

Amplified Sciences, a clinical-stage diagnostics company pioneering next-generation multi-omic assays, today announced a new investment from the American Gastroenterological Association's (AGA) GI Opportunity Fund as part of its recent Seed+ financing round.

4 Jun 2026

EULAR 2026 highlights rising comorbidity risks in rheumatic disease

People with rheumatic and musculoskeletal diseases (RMD) are at risk of a number of comorbidities, from cardiovascular diseases to cognitive impairment and fractures.

4 Jun 2026

Study shows early disease activity predicts systemic sclerosis progression

In an oral abstract presentation on Thursday 4th June, results were shared from a longitudinal observational analysis of the EUSTAR database – a large multicenter online database that prospectively follows more than 25,000 patients across over 200 international centers.

4 Jun 2026

Early glucocorticoid tapering reduces damage in vasculitis maintenance therapy

Glucocorticoids are the cornerstone of initial vasculitis treatment, used to rapidly control inflammation and protect vital organs.

4 Jun 2026

Study links remote work to increased isolation and depression

The rise in remote work caused by the COVID-19 pandemic has substantially increased time spent alone and worsened workers' mental health, according to a new study based on survey data from more than 500,000 Americans.

4 Jun 2026